← Live Studies
KaiNETIC-1: Ribupatide for obesity without diabetes
Compares once-weekly investigational ribupatide (KAI-9531) injections with placebo on body weight in adults with obesity, or overweight with a weight-related condition, who do not have diabetes.
This study is no longer recruiting. According to its ClinicalTrials.gov record, enrollment is complete. It is listed here for reference.
Who it's for
- Age 18+
- BMI ≥30, or ≥27 with a weight-related condition
- Diabetes excluded
Full eligibility rules apply. The study team decides who can take part.
Where it runs
4 research locations in Arizona, California and Utah.
Arizona
- Kailera clinical site (name not disclosed)Sun City, AZ
California
- Kailera clinical site (name not disclosed)Escondido, CA
- Kailera clinical site (name not disclosed)Toluca Lake, CA
Utah
- Kailera clinical site (name not disclosed)Salt Lake City, UT
These sites are not enrolling new participants for this study. The official record lists every location, including outside these states.
Looking for a study that is enrolling?
See the studies that are recruiting now, or tell us you are interested in research and we will help you find one.

